Perrigo Company plc CEO Lashes Out Against Mylan NV $27 Billion Offer
Permalink

Perrigo Company plc CEO Lashes Out Against Mylan NV $27 Billion Offer

However, Mylan says Perrigo’s stock, which stood at around $164 before Mylan’s approach, has been…

Continue Reading →

Teva buys Allergan’s generic drugs business for $40.5 billion
Permalink

Teva buys Allergan’s generic drugs business for $40.5 billion

Teva Pharmaceutical’s acquisition of the Allergan’s unit will make it the world’s No. 1 distributor…

Continue Reading →

Advertisement

Israel’s Teva buys Allergan generic drug company for $40.5B
Permalink

Israel’s Teva buys Allergan generic drug company for $40.5B

In a deal which had been anticipated, Teva Pharmaceutical Industries (NYSE: TEVA) announced it would…

Continue Reading →